Life Sciences Practice
Life Sciences Executive Search
Life sciences organizations move through discrete inflection points, and each one calls for a different leadership profile.
Financing, clinical milestones, regulatory approval, and commercialization each change what an organization needs from its leaders. A team that has taken an asset through development is not automatically the team that can launch it.
We search across pharmaceuticals, biotechnology, biopharma, medical devices, diagnostics, and life sciences services, assessing leaders against therapeutic area experience, stage-appropriate scale, regulatory record, and the capital environment the organization operates within.
Pharmaceutical and biopharma leadership
Established pharmaceutical organizations require leaders who can operate matrix structures, manage portfolio decisions across geographies, and maintain regulatory and quality accountability at scale.
Biotech leadership
Clinical-stage organizations need leaders who can hold investor confidence through milestone risk while building the functions the company does not yet have. The transition from clinical-stage to commercial-stage leadership is the most consistently underestimated appointment in the sector.
- Chief Executive Officer
- Chief Medical Officer
- Chief Scientific Officer
- Chief Financial Officer
- Chief Technical Operations Officer
MedTech and medical device leadership
Device and diagnostics organizations combine engineering, regulatory, and commercial disciplines. Leadership candidates are assessed on class-specific regulatory experience and on their record with the relevant call point and reimbursement model.
Commercial leadership and market access
Launch readiness depends on commercial leadership that understands pricing, reimbursement, payer negotiation, and health economics — not simply sales management. Market access capability is frequently the constraint on a successful launch.
Regulatory, clinical development, and quality
Regulatory affairs, clinical development, and quality leadership carry direct accountability for approval timelines and for the organization's standing with regulators. These searches are narrow by definition and require precise mapping.
Manufacturing and supply chain scale-up
Technical operations leadership becomes decisive as an organization moves from clinical supply to commercial manufacture, whether internally or through partners.
Life sciences board search
Boards in the sector need scientific, regulatory, commercial, and capital markets perspective in proportion to the company's stage. Composition typically needs to evolve at each financing and approval milestone.
Market intelligence in life sciences
Talent concentrates in defined clusters, equity weighting is often decisive in executive decisions, and stage-transition experience is scarce and heavily contested. These conditions shape realistic expectations before a search opens.
Next step
Discuss a life sciences leadership appointment.
Every conversation with Thalvern Advisory is confidential and without obligation.